跳至主要内容
临床试验/NCT03705962
NCT03705962终止3 期

Locally Applied Antibiotics for Infection Prophylaxis in Treatment of Open Fractures

University of Virginia1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2015年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
11
试验地点
1
主要终点
Presence of Wound Infection

研究概览

简要总结

The primary objective of this study is to investigate the effectiveness of local antibiotic versus placebo in the prevention of infections in open fractures. The study will assess whether local treatment of open fractures with the antibiotic tobramycin (in addition to standard systemic antibiotics) will decrease the risk and rate of infection, and rate of re-operation. This will be studied using a randomized controlled clinical trial design in adult population of age 18-70 years who present with open fractures. About 133 subjects will be recruited in this study at UVA.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ages 18 - 70 years
  • Gustilo Type I,II,IIIa open fracture (s)
  • Ability to provide informed consent (or proxy consent in cases where subject is temporarily impaired when intubated and sedated)
  • Subject should be able to follow up at the scheduled times following surgery
  • Subjects who may have compartment syndrome, renal insufficiency, and those who are immunosuppressed regardless of antibiotic administration will also be included in the study

排除标准

  • Closed fracture
  • Severe injury requiring flap coverage or vascular reconstruction (Gustilo-Anderson Type IIIB and C respectively)
  • Aminoglycoside allergy
  • Presentation greater than 48 hours after injury
  • Pathologic fracture
  • Preexisting infection in bone with an open fracture
  • Patients with multiple trauma involving liver, kidney, or brain
  • Pregnancy (self-reported)
  • Current status as prisoner

研究组 & 干预措施

Antibiotic

Experimental

Subjects will be injected locally at the wound cavity (i.e. fracture site, surrounding soft tissue which include muscle, and subcutaneous space) with 80mg/40mL of tobramycin after wound closure. Systemic antibiotic will not be withheld and will be done along side the intervention.

干预措施: Tobramycin (Drug)

结局指标

主要结局

Presence of Wound Infection

时间窗: 6 weeks post op

Infection will be defined as major and minor, with major indicated by return to the operating room for irrigation and debridement. Minor infection is represented by documentation of cellulitis or superficial infection at surgical site and administration of oral antibiotics

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Seth Yarboro, MD

Assistant Professor Orthopaedic Surgery

University of Virginia

研究点 (1)

Loading locations...

相似试验

Locally Applied Antibiotics for Infection... | 临床试验